139 related articles for article (PubMed ID: 37170089)
1. Comparison between radical surgery and chemoradiotherapy in patients with cervical esophageal cancer: a propensity score matched analysis.
Qi K; Lin G; Liu H; Zhang X; Chen Z; Li J
BMC Surg; 2023 May; 23(1):119. PubMed ID: 37170089
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy alone for patients with locally advanced rectal cancer: a propensity-score-matched analysis combined with SEER validation.
Wu J; Huang M; Wu Y; Hong Y; Cai L; He R; Luo Y; Wang P; Huang M; Lin J
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8897-8912. PubMed ID: 37154929
[TBL] [Abstract][Full Text] [Related]
3. Survival differences between chemotherapy and chemoradiotherapy in metastatic esophageal cancer: a propensity score-matched study based on the SEER database.
Shao Y; Zhang M; Ye L; Chen D; Wu QC; Zhang C
Ann Palliat Med; 2021 Apr; 10(4):3826-3835. PubMed ID: 33691433
[TBL] [Abstract][Full Text] [Related]
4. Propensity Score Analysis of Radical Hysterectomy Versus Definitive Chemoradiation for FIGO Stage IIB Cervical Cancer.
Tomita N; Mizuno M; Makita C; Kondo S; Mori M; Sakata J; Tsubouchi H; Hirata K; Tachibana H; Kodaira T
Int J Gynecol Cancer; 2018 Oct; 28(8):1576-1583. PubMed ID: 30095702
[TBL] [Abstract][Full Text] [Related]
5. Comparison Between Esophagectomy and Definitive Chemoradiotherapy in Patients With Esophageal Cancer.
Wang BY; Hung WH; Wu SC; Chen HC; Huang CL; Lin CH; Chen HS
Ann Thorac Surg; 2019 Apr; 107(4):1060-1067. PubMed ID: 30571951
[TBL] [Abstract][Full Text] [Related]
6. Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis.
Nomura M; Oze I; Kodaira T; Abe T; Komori A; Narita Y; Masuishi T; Taniguchi H; Kadowaki S; Ura T; Andoh M; Tachibana H; Uemura N; Tajika M; Niwa Y; Muto M; Muro K
Int J Clin Oncol; 2016 Oct; 21(5):890-898. PubMed ID: 26980212
[TBL] [Abstract][Full Text] [Related]
7. Survival benefit of combined immunotherapy and chemoradiotherapy in locally advanced unresectable esophageal cancer: an analysis based on the SEER database.
Xie L; Zhang Z
Front Immunol; 2024; 15():1334992. PubMed ID: 38292873
[TBL] [Abstract][Full Text] [Related]
8. Survival benefit of surgery with postoperative radiotherapy in locally advanced cervical adenocarcinoma: a population-based analysis.
Wang X; Lu X; Chen J; Yi H; Lan Q
BMC Surg; 2023 Oct; 23(1):299. PubMed ID: 37789291
[TBL] [Abstract][Full Text] [Related]
9. Treatment and Prognosis of Resectable Cervical Esophageal Cancer: A Population-Based Study.
Xu L; Chen XK; Xie HN; Wang Z; Qin JJ; Li Y
Ann Thorac Surg; 2022 Jun; 113(6):1873-1881. PubMed ID: 34329601
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China.
Zhang G; Zhang C; Sun N; Xue L; Yang Z; Fang L; Zhang Z; Luo Y; Gao S; Xue Q; Mu J; Gao Y; Tan F; He J
J Cancer Res Clin Oncol; 2022 Apr; 148(4):943-954. PubMed ID: 34013382
[TBL] [Abstract][Full Text] [Related]
11. Surgery of primary sites for stage IVB cervical cancer patients receiving chemoradiotherapy: a population-based study.
Li H; Pang Y; Cheng X
J Gynecol Oncol; 2020 Jan; 31(1):e8. PubMed ID: 31788998
[TBL] [Abstract][Full Text] [Related]
12. Postoperative adjuvant chemotherapy versus chemoradiotherapy for node-positive esophageal squamous cell carcinoma: a propensity score-matched analysis.
Wang Q; Lang J; Li T; Peng L; Dai W; Jiang Y; Xie T; Fang Q; Wang Y; Wu L; Cao B; Han Y
Radiat Oncol; 2020 May; 15(1):119. PubMed ID: 32448253
[TBL] [Abstract][Full Text] [Related]
13. Distinguish the Role of Radiotherapy From Chemoradiotherapy for Gastric Cancer With Behavior of Metastasis-Indolent in Lymph Node.
Zhi Y; Lin Z; Ma J; Mou W; Chen X
Technol Cancer Res Treat; 2020; 19():1533033820959400. PubMed ID: 33148125
[TBL] [Abstract][Full Text] [Related]
14. Chemoradiotherapy Is Superior to Radiotherapy Alone in Esophageal Cancer Patients Older Than 65 Years: A Propensity Score-Matched Analysis of the SEER Database.
Xia X; Gao Q; Ge X; Liu Z; Di X; Sun X; Yang Y
Front Oncol; 2021; 11():736448. PubMed ID: 34557416
[TBL] [Abstract][Full Text] [Related]
15. Treatment patterns and survival in T4b esophageal cancer: a retrospective cohort study.
Yu BB; Huang JQ; Liang HW; Liu Y; Chen L; Pei S; Huang W; Pan XB
Aging (Albany NY); 2024 Apr; 16(8):7131-7140. PubMed ID: 38643464
[TBL] [Abstract][Full Text] [Related]
16. Chemoradiotherapy vs radiotherapy for nonoperative early stage esophageal cancer: A seer data analysis.
Li J; Jia Y; Cheng Y; Wang J
Cancer Med; 2020 Jul; 9(14):5025-5034. PubMed ID: 32441890
[TBL] [Abstract][Full Text] [Related]
17. Chemoradiotherapy vs radiotherapy for non-surgical locally advanced laryngeal squamous cell carcinoma patients: a propensity score-matched study and practical nomogram construction.
Zhang Y; Wang Z; Zheng Y
Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1449-1456. PubMed ID: 38158418
[TBL] [Abstract][Full Text] [Related]
18. The Effectiveness of Chemoradiotherapy in Elderly Patients with Pancreatic Cancer: A Population-Based Study Based on the SEER Database.
Nie D; Liu S; Cai S; Xing X; Xu F
Adv Ther; 2022 Nov; 39(11):5043-5057. PubMed ID: 36044179
[TBL] [Abstract][Full Text] [Related]
19. Pre- versus postoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
Hsu PK; Chen HS; Liu CC; Huang CS; Hsieh CC; Hsu HS; Wu SC
J Thorac Cardiovasc Surg; 2017 Aug; 154(2):732-740.e2. PubMed ID: 28457536
[TBL] [Abstract][Full Text] [Related]
20. Role of Radical Surgery Following Preoperative Chemoradiotherapy in Octogenarians With Rectal Cancer: A SEER Analysis.
Lim YJ; Kong M
Anticancer Res; 2024 Jan; 44(1):417-425. PubMed ID: 38159981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
